EU and U.S. signed a bilateral agreement on insurance and reinsurance. The agreement will boost consumer protection and cut costs and red tape for EU insurers and reinsurers active in the U.S. In a joint statement, the EU and the U.S. said: “The Agreement represents a major step forward in U.S.- EU cooperation on insurance and reinsurance, conveying benefits to EU and U.S. insurers and reinsurers operating across the Atlantic, by offering them enhanced regulatory certainty, while maintaining robust consumer protections.” The signature allows parts of the agreement to become immediately applicable on a provisional basis. The European Parliament and the Council will need to approve the conclusion of the agreement.
The signature marks the final step in more than 20 years of discussions and a year of formal negotiations between EC and the U.S. Department of the Treasury and Office of the Trade Representative. Regarding reinsurance, the agreement will lead to the elimination of collateral and local presence requirements for EU and U.S. reinsurers operating in each other's markets. In line with the objectives of the Investment Plan for Europe and the Capital Markets Union, the agreement will enable reinsurers to boost their investment capacity. The agreement will enhance consumer protection by facilitating the exchange of information between EU and U.S. supervisors. The agreement also brings prudential benefits: for example, EU insurers and reinsurers will have to prepare only one risk and solvency assessment (ORSA) in light of their risk profiles.
Keywords: Europe, Americas, EU, United States of America, Insurance, Reinsurance, Bilateral Agreement, ORSA, EC
Previous ArticleEBA Single Rulebook Q&A: Third Update for December 2017
Next ArticleESMA Updated Q&A on Market Abuse Regulation
APRA has concluded its review of the comprehensive plans of authorized deposit-taking institutions for the assessment and management of loans with repayment deferrals.
ESAs (EBA, EIOPA, and ESMA) published the first joint report that assesses risks in the financial sector since the outbreak of the COVID-19 pandemic.
BoE and HM Treasury confirmed that the COVID Corporate Financing Facility (CCFF) will close for new purchases of commercial paper, with effect from March 23, 2021.
ECB published a decision allowing the euro area banks under its direct supervision to exclude certain central bank exposures from the leverage ratio.
ESAs launched a survey seeking feedback on the presentational aspects of product templates under the Sustainable Finance Disclosure Regulation (SFDR or Regulation 2019/2088).
ECB published input of the European System of Central Banks (ESCB) into the EBA feasibility report on reducing the reporting burden for banks in EU.
EC adopted a decision determining, for a limited period of time, that the regulatory framework applicable to central counterparties, or CCPs, in the UK and Northern Ireland is equivalent to the requirements laid down in the European Market Infrastructure Regulation (EMIR or Regulation 648/2012).
EBA has decided to phase out the guidelines on legislative and non-legislative moratoria of loan repayments, in accordance with the earlier specified end of September deadline.
EBA published an Opinion addressed to EC to raise awareness about the opportunity to clarify certain issues related to the definition of credit institution in the upcoming review of the Capital Requirements Directive and Regulation (CRD and CRR).
ECB finalized the guide on assessment methodology for the internal model method for calculating exposure to counterparty credit risk (CCR) and the advanced method for own funds requirements for credit valuation adjustment (A-CVA) risk.